ALEXIS-AIDT-2-MPM

N/A

Report date: 2022/09/06 18:12:13

Base Information

Drug NameALEXIS-AIDT-2-MPM

Drug Alias NameN/A

ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy > Chimeric antigen receptor NK cell therapy

Mechanisms of ActionT lymphocyte replacementsImmunologic cytotoxicity

TargetsNot applicable

Therapy Area/IndicationsMesothelioma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesKiromic Biopharma Inc

China Registration ClassN/A

Develop Information

Active CompaniesKiromic Biopharma Inc

Inactive CompaniesN/A

Active IndicationsMesothelioma

Inactive IndicationsN/A

Other Information

ATC CodeN/A